Call for Abstract
5th International Conference on Oncology and Cancer, will be organized around the theme “Explore the Latest Innovative Treatment and Prevention of Oncology and Cancer”
Cancer Summit 2023 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cancer Summit 2023
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Oncology is the study of tumour or cancer. Most of the tumours are not cancerous. The cancerous tumours are called malignant tumours. Commonly oncology implies the study of malignant tumours or cancer. The doctor who practices oncology is an oncologist. There are different kinds of oncologists. Those who practiced in surgery are called surgical oncologists. Those who practiced in radiation therapy are called . Those who practiced in the care of persons with cancer and administer chemotherapy are medical oncologists.
Neurosurgical Oncology is a complex surgical method that presupposes treatment, diagnosis, and rehabilitation of disorders affecting any region of the Nervous System. Some of the preponderance is common Neuro surgeries are skull base surgery, Image Guided Surgery, Laser Surgery, Spinal and Neuro surgical treatment
A Nursing Oncology will gives care to growth patients and those are in danger for getting the sickness. They screen physical conditions, recommend solution and oversee chemotherapy and many medications for cancer. is a standout among the most crucial and remunerating fields in nursing. One of the crucial parts of the cancer nurture is quiet appraisal. They are in charge of surveying patients who have initiated because of treatment reactions, and also evaluating patients, amid and post-chemotherapy. The oncology nurture necessary to have the capacity to comprehend pathology comes about and their suggestions, and have an inside and out learning of the normal symptoms of growth medicines. The oncology nurture like to utilize her relational aptitudes to tune in to the patient, surveying their comprehension of the malady and its procedure and also the patient's passionate state.
The Central Nervous System is denounced to various malevolent personality disorders. Central Nervous System covers its mechanism, Metastatic pestilence, Ramification, Cancers, Neurons and Sensory Receptors, Neurological Disorders, Multiple sclerosis and Imaging agents to CNS neurofibromatosis. Cancer spreads to the Nervous System by direct invasion or compression from continuous tissues relates to the proximity of the Nervous System to other structures. Drugs market to grow at a CAGR of -3.2% over the period 2013-2018. The central nervous system (CNS) therapeutics peddle has been forecast to reach US$133 billion by the year 2018, which increases in disease ubiquity rates due to increase in population, introduction of new drugs, and increased outgo on healthcare.
Brain Tumour develops when abnormal cells form inside the brain. The symptoms of vary greatly and can involve Ataxia, Cranial Nerve Palsy, headaches, problems with speech and swallowing, hearing loss, weakness, Hemiparesis, vision abnormalities, ptosis, and behavioural changes. Another possible symptom is vomiting. Any brain tumour is inherently serious and life-threatening because of its infiltrative character in the limited space of the Intracranial Cavity.
Due to Cancers millions of death occurring every year. The study of cancer biology is one of the largest areas of scientific interest. progress specific hallmarks through a series of mutations in both oncogenes and tumour-suppressor genes. There is no definitive cure for cancer, the most of the cancer treatments serve to prolong the lives of cancer sufferers.
Cancer metabolomics research is being used to discover diagnostic cancer biomarkers in the clinic, to better understand its complex heterogeneous nature, to discover pathways involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. Cancer metabolomics approaches may also provide clues to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate goal of most studies is to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient.
Cancer is a genetic disease affected by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation. The ambition of is to determined new oncogenes or tumour suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies like Gleevec, Herceptin and a vast in raised the hope for oncogenomics to elucidate new targets for cancer treatment.